1965. Safety and Efficacy of Glecaprevir/Pibrentasvir in Patients With Chronic Hepatitis C Virus Genotypes 1–6 and Human Immunodeficiency Virus-1 Co-Infection: An Integrated Analysis of Two Phase 3 Clinical Trials

BACKGROUND: People co-infected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV)-1 may be treated for HCV without special considerations apart from drug interactions with antiretroviral therapies (ART). The once-daily, all-oral, ribavirin-free, pangenotypic combination of glecaprev...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockstroh, Jurgen K, Bhagani, Sanjay R, Orkin, Chloe, Soto-Malave, Ruth, Lacombe, Karine, Zhang, Zhenzhen, Wang, Stanley, Mensa, Federico, Trinh, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252827/
http://dx.doi.org/10.1093/ofid/ofy210.1621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252827/
http://dx.doi.org/10.1093/ofid/ofy210.1621

Ejemplares similares